FOVEA PHARMACEUTICALS

Fovea Pharmaceuticals is a French biopharmaceutical company. It discovers and develops drugs for the treatment of ocular diseases. The company offers FOV1101 Prednisporin for the treatment of allergic conjunctivitis; FOV2302, a proprietary plasma kallikrein-kinin inhibitor for the systemic treatment of hereditary angioedema; FOV2304 for the treatment of diabetic macular edema; and FOV2501, an intravitreal formulation of RdCVF designed to treat retinitis pigmentosa with extension to dry age-related macular degeneration. Fovea Pharmaceuticals was founded in 2005 and is based in Paris, France. As of October 30, 2009, it operates as a subsidiary of Sanofi.

#SimilarOrganizations #People #Financial #Website #More

FOVEA PHARMACEUTICALS

Industry:

Biotechnology Health Care Medical Pharmaceutical

Founded:

2005-01-01

Address:

Paris, Ile-de-France, France

Country:

France

Website Url:

http://www.fovea-pharma.com

Total Employee:

Status:

Closed

Total Funding:

107.01 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Nginx SAKURA Internet

Similar Organizations

tibotec-logo

Tibotec

Tibotec is a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV .

Current Advisors List

tim-haines_image

Tim Haines Board of Directors @ Fovea Pharmaceuticals
Board_member

Current Employees Featured

pierre-belichard_image

Pierre Belichard
Pierre Belichard Founder & COO @ Fovea Pharmaceuticals
Founder & COO

Founder

bernard-gilly_image

Bernard Gilly

pierre-belichard_image

Pierre Belichard

Investors List

abingworth-management_image

Official Site Inspections

http://www.fovea-pharma.com

Host Informations
Whois Informations

Loading ...